Results 21 to 30 of about 2,592,842 (396)

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

New England Journal of Medicine, 2020
Background Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion ...
L. Baden, Hana M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. Spector, N. Rouphael, C. Creech, J. Mcgettigan, Shishir Kehtan, N. Segall, Joel Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, Honghong Zhou, Shu Han, M. Ivarsson, Jacqueline M. Miller, T. Zaks   +36 more
semanticscholar   +1 more source

COVID-19 and newborn health: systematic review

Revista Panamericana de Salud Pública, 2020
Objective. To describe perinatal and neonatal outcomes in newborns exposed to SARS-CoV-2. Methods. A systematic review was conducted by searching PubMed Central, LILACS, and Google Scholar using the keywords ‘covid’ AND ‘newborn’ OR ‘child’ OR ‘infant ...
Pablo Duran, Stephen Berman, Susan Niermeyer, Thomas Jaenisch, Thais Forster, Rodolfo Gomez Ponce de Leon, Bremen De Mucio, Suzanne Serruya   +7 more
doaj   +1 more source

Sleep-wake cycle impairment adding on the risk for COVID-19 severity in people with diabetes [PDF]

Sleep Science, 2020
In the present article, we explore the risks of circadian disruptions and impact on the sleepwake cycle of individuals with diabetes during COVID-19 pandemic.
Mark Thomaz Ugliara Barone, Belinda Ngongo, Luiz Menna-Barreto   +2 more
doaj   +1 more source

The proximal origin of SARS-CoV-2

Nature Medicine, 2020
SARS-CoV-2 is the seventh coronavirus known to infect humans; SARSCoV, MERS-CoV and SARS-CoV-2 can cause severe disease, whereas HKU1, NL63, OC43 and 229E are associated with mild symptoms6. Here we review what can be deduced about the origin of SARS-CoV-
Kristian G. Andersen, Kristian G. Andersen, A. Rambaut, W. Lipkin, E. Holmes, R. Garry   +5 more
semanticscholar   +1 more source

Evaluating COVID-19’s impact on the training of residents at the University of Antioquia from January to June 2020

Iatreia, 2023
Objective: To evaluate the impact of the COVID-19 pandemic on the academic development of residents in medical and surgical specialties at the University of Antioquia through an online survey.
Adolfo Alejandro Lopez-Ríos, Evert Armando Jiménez-Cotes, Nelson Darío Giraldo-Ramírez, Alfredo Salvador Patrón-Gómez   +3 more
doaj   +1 more source

The challenges in the treatment of large burned and polytraumatized patients with arterial thrombosis in the lower limb during the COVID-19 pandemic: a case report [PDF]

Revista Brasileira de Cirurgia Plástica, 2023
Introduction: The COVID-19 pandemic spread rapidly worldwide, bringing the need for emergency actions to control the disease at the collective and individual level.
Rafael Eiki Takemura, Gregory Nicolas, Alexandre Wada, David de Souza Gomez, Rolf Gemperli   +4 more
doaj   +1 more source

The SARS-CoV-2 virus [PDF]

, 2021
Viruses are non-living particles containing genetic information in the form of DNA or RNA. They are fascinating because they are not considered a form of life even though they evolve in the same way all living organisms do. Viruses are so-called obligate pathogens because they cannot multiply unless they infect and hijack the cellular machinery in ...
Frida Sommer, Ernesto Llamas
openaire   +1 more source

A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virus

Science Translational Medicine, 2021
There is an urgent need for an effective, oral, direct-acting therapeutic to block transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prevent progression to severe coronavirus disease 2019 (COVID-19).
W. Fischer, J. Eron, W. Holman, M. Cohen, L. Fang, L. J. Szewczyk, T. Sheahan, R. Baric, K. Mollan, Cameron R. Wolfe, E. Duke, M. Azizad, K. Borroto-Esoda, D. Wohl, R. Coombs, A. Loftis, P. Alabanza, F. Lipansky, W. Painter   +18 more
semanticscholar   +1 more source

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Nature Microbiology, 2020
The present outbreak of a coronavirus-associated acute respiratory disease called coronavirus disease 19 (COVID-19) is the third documented spillover of an animal coronavirus to humans in only two decades that has resulted in a major epidemic.
Alexander E. Susan C. Ralph S. Raoul J. Christian Anastasia Gorbalenya Baker Baric de Groot Drosten Gulyaeva H, A. Gorbalenya, S. Baker, R. Baric, R. D. de Groot, C. Drosten, Anastasia A. Gulyaeva, B. Haagmans, C. Lauber, A. M. Leontovich, B. Neuman, Dmitry Penzar, S. Perlman, L. Poon, Dmitry V. Samborskiy, I. Sidorov, I. Sola, J. Ziebuhr   +17 more
semanticscholar   +1 more source

Aptamer Blocking Strategy Inhibits SARS‐CoV‐2 Virus Infection

Angewandte Chemie, 2021
The COVID‐19 pandemic caused by SARS‐CoV‐2 is threating global health. Inhibiting interaction of the receptor‐binding domain of SARS‐CoV‐2 S protein (SRBD) and human ACE2 receptor is a promising treatment strategy.

semanticscholar   +1 more source